GlobalData on MSN
Compass’ psilocybin shows six-month durability in Phase III trial
Compass has already submitted for approval of its psilocybin-based therapy to the FDA following previous Phase III success.
The global Java development ecosystem experienced significant structural changes this week following the introduction of a new OpenJDK enhancement draft alongside warnings from cybersecurity ...
Compass Pathways plc upgraded to Strong Buy after phase 3 COMP360 TRD data & fast-track FDA NDA review; see catalysts, ...
Totem, Inc. today announced a major technical milestone following Electric Forest 2026, where Totem Compasses helped ...
Tierney Plumb is an editor of Eater’s Northeast region, covering D.C., Boston, Philly, and New York. This is Eater’s running guide to all the D.C. restaurants, bars, and cafes that closed over the ...
Explore the latest news and expert commentary on Vulnerabilities & Threats, brought to you by the editors of Dark Reading ...
Q&A: Temporal aims to be the reliability backbone for an agentic AI economy Temporal Co-founder and CEO Samar Abbas weighs in on AI reliability, execution and what IT decision-makers should to keep in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results